Insulin API Market Report – Research, Industry Analysis Reports and Market Demands

Global Insulin API Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Insulin API Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Insulin API Market Size Growth Rate by Product
- 1.4.2 Regular Human Insulin
- 1.4.3 Insulin Analogue
1.5 Market by End User
- 1.5.1 Global Insulin API Market Size Growth Rate by End User
- 1.5.2 Fast-acting
- 1.5.3 Premix
- 1.5.4 Long-acting
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Insulin API Market Size
- 2.1.1 Global Insulin API Revenue 2014-2025
- 2.1.2 Global Insulin API Sales 2014-2025
2.2 Insulin API Growth Rate by Regions
- 2.2.1 Global Insulin API Sales by Regions
- 2.2.2 Global Insulin API Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Insulin API Sales by Manufacturers
- 3.1.1 Insulin API Sales by Manufacturers
- 3.1.2 Insulin API Sales Market Share by Manufacturers
- 3.1.3 Global Insulin API Market Concentration Ratio (CR5 and HHI)
3.2 Insulin API Revenue by Manufacturers
- 3.2.1 Insulin API Revenue by Manufacturers (2014-2019)
- 3.2.2 Insulin API Revenue Share by Manufacturers (2014-2019)
3.3 Insulin API Price by Manufacturers
3.4 Insulin API Manufacturing Base Distribution, Product Types
- 3.4.1 Insulin API Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insulin API Product Type
- 3.4.3 Date of International Manufacturers Enter into Insulin API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Insulin API Sales by Product
4.2 Global Insulin API Revenue by Product
4.3 Insulin API Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Insulin API Breakdown Data by End User

6 North America

6.1 North America Insulin API by Countries
- 6.1.1 North America Insulin API Sales by Countries
- 6.1.2 North America Insulin API Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Insulin API by Product
6.3 North America Insulin API by End User

7 Europe

7.1 Europe Insulin API by Countries
- 7.1.1 Europe Insulin API Sales by Countries
- 7.1.2 Europe Insulin API Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Insulin API by Product
7.3 Europe Insulin API by End User

8 Asia Pacific

8.1 Asia Pacific Insulin API by Countries
- 8.1.1 Asia Pacific Insulin API Sales by Countries
- 8.1.2 Asia Pacific Insulin API Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Insulin API by Product
8.3 Asia Pacific Insulin API by End User

9 Central & South America

9.1 Central & South America Insulin API by Countries
- 9.1.1 Central & South America Insulin API Sales by Countries
- 9.1.2 Central & South America Insulin API Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Insulin API by Product
9.3 Central & South America Insulin API by End User

10 Middle East and Africa

10.1 Middle East and Africa Insulin API by Countries
- 10.1.1 Middle East and Africa Insulin API Sales by Countries
- 10.1.2 Middle East and Africa Insulin API Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Insulin API by Product
10.3 Middle East and Africa Insulin API by End User

11 Company Profiles

12 Future Forecast

12.1 Insulin API Market Forecast by Regions
- 12.1.1 Global Insulin API Sales Forecast by Regions 2019-2025
- 12.1.2 Global Insulin API Revenue Forecast by Regions 2019-2025
12.2 Insulin API Market Forecast by Product
- 12.2.1 Global Insulin API Sales Forecast by Product 2019-2025
- 12.2.2 Global Insulin API Revenue Forecast by Product 2019-2025
12.3 Insulin API Market Forecast by End User
12.4 North America Insulin API Forecast
12.5 Europe Insulin API Forecast
12.6 Asia Pacific Insulin API Forecast
12.7 Central & South America Insulin API Forecast
12.8 Middle East and Africa Insulin API Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Insulin API Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
The overall domestic policy for the development of insulin API is supported. Local governments have a lot of policies to support the development of the industry. But in recent years environmental protection requirements for the fermentation industry are also getting higher and higher.
The global Insulin API market is valued at 1660 million US$ in 2018 and will reach 2320 million US$ by the end of 2025, growing at a CAGR of 4.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin API market based on company, product type, end user and key regions.

This report studies the global market size of Insulin API in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin API in these regions.
This research report categorizes the global Insulin API market by top players/brands, region, type and end user. This report also studies the global Insulin API market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
Julphar Diabetes
Wockhardt

Market size by Product
Regular Human Insulin
Insulin Analogue
Market size by End User
Fast-acting
Premix
Long-acting

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Insulin API market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin API market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin API companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin API submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin API are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin API market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.